Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hanke

Showing results (1-10 of 148) with videos related to

Pageof 15
Sort By:
Current Molecular Medicine|March 20, 2002
Vehicles for genetic vaccines against human immunodeficiency virus: induction of T cell-mediated immune responsesT Hanke
British Medical Bulletin|November 21, 2001
Prospect of a prophylactic vaccine for HIVT Hanke
Folia Biologica|September 18, 2004
Prospects for an effective T cell-based immunoprophylaxis against mother-to-child transmission of HIV-1T Hanke
The Journal of Chemical Physics|January 15, 2026
Optimizing the sensitivity of the instantaneous entropy of mixingT Hanke, D Sebastiani
Immunology Letters|April 15, 1999
Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDST Hanke, A McMichael
Herz|October 21, 2011
[Surgical atrial fibrillation ablation therapy and postoperative monitoring]T Hanke, H-H Sievers
Nature Medicine|June 17, 1999
Is an HIV vaccine possible?A J McMichael, T Hanke
Nature Medicine|September 6, 2000
Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in KenyaT Hanke, A J McMichael
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2001
Cumulative inhibition of NK cells and T cells resulting from engagement of multiple inhibitory Ly49 receptorsT Hanke, D H Raulet
Trends in Biotechnology|March 18, 2014
Purifying biopharmaceuticals: knowledge-based chromatographic process developmentAlexander T Hanke, Marcel Ottens
Pageof 15

Showing results (1-10 of 148) with videos related to

Sort By:
Pageof 15
Current Molecular Medicine|March 20, 2002
Vehicles for genetic vaccines against human immunodeficiency virus: induction of T cell-mediated immune responsesT Hanke
British Medical Bulletin|November 21, 2001
Prospect of a prophylactic vaccine for HIVT Hanke
Folia Biologica|September 18, 2004
Prospects for an effective T cell-based immunoprophylaxis against mother-to-child transmission of HIV-1T Hanke
The Journal of Chemical Physics|January 15, 2026
Optimizing the sensitivity of the instantaneous entropy of mixingT Hanke, D Sebastiani
Immunology Letters|April 15, 1999
Pre-clinical development of a multi-CTL epitope-based DNA prime MVA boost vaccine for AIDST Hanke, A McMichael
Herz|October 21, 2011
[Surgical atrial fibrillation ablation therapy and postoperative monitoring]T Hanke, H-H Sievers
Nature Medicine|June 17, 1999
Is an HIV vaccine possible?A J McMichael, T Hanke
Nature Medicine|September 6, 2000
Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in KenyaT Hanke, A J McMichael
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2001
Cumulative inhibition of NK cells and T cells resulting from engagement of multiple inhibitory Ly49 receptorsT Hanke, D H Raulet
Trends in Biotechnology|March 18, 2014
Purifying biopharmaceuticals: knowledge-based chromatographic process developmentAlexander T Hanke, Marcel Ottens
Pageof 15